A research team at MIT, led by Dr. Kripa Varanasi, has figured out a way around one of the major barriers to the delivery of concentrated biologic drugs.
My family’s dog, Rory, has always been weird. He will start screaming if, while running around the house like a maniac, he accidentally stubs his toe. He loves eating carrots. He gets jealous if two people are hugging and he isn’t included. He will only lie down on the softest pillow on the couch. He likes to sit on our laps after we’ve eaten dinner and flops over with wild abandon, confident that someone will catch him before he falls. He has been known to collect items such as books, shoes, and pencils in a particular corner of the living room. He is exceptionally food motivated and sometimes obnoxious in his relentless pursuit of affection.
Researchers at Duke University have developed a simple, low-cost method to assess the efficacy of different face masks at reducing the transmission of respiratory droplets during normal speech. Respiratory droplets are believed to be the primary way that people spread SARS-CoV-2 to one another.
Researchers at Pohang University of Science & Technology have developed a novel technique to affinity tag and purify recombinant proteins. Their method does not rely on protein-based affinity ligands, but rather utilizes cucurbiturils, a family of macrocyclic molecules named after their resemblance to pumpkins (family Cucurbitaceae).
Development of COVID-19 vaccines is moving forward at an unprecedented pace, and the public interest and press coverage are huge. And yet it is not easy for lay person or scientist to keep track of the multitude of vaccine candidates.